PremiumThe FlyPacBio price target lowered to $2 from $6 at Scotiabank Insider Trading Shakes Up Pacific Biosciences, Nutanix, Coupang, CSX, and Williams Co Largest borrow rate increases among liquid names PremiumRatingsPacific Biosciences: Hold Rating Amid Revenue Guidance Challenges and Positive Vega System Prospects PacBio grants equity incentive award to new employee PacBio’s 2024 Earnings: Growth Amid Challenges PremiumRatingsPacific Biosciences: Strategic Growth Amidst Funding Challenges Supports Buy Rating PacBio Navigates Financial Challenges with Strategic Advances Pacific Biosciences: Buy Rating Amidst Conservative Guidance and Strategic Growth Initiatives 
